Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) - P/B ratio

P/B ratio as of December 2025 : 0.7362

According to Galapagos NV's latest financial reports the company has a price-to-book ratio of 6.60362.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Galapagos NV - P/B ratio (from 2008 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-310.5968-31.15%
2023-12-310.8668-19.62%
2022-12-311.08-11.64%
2021-12-311.22-38.1%
2020-12-311.97-52.99%
2019-12-314.1916.07%
2018-12-313.61-8.65%
2017-12-313.965.92%
2016-12-313.73-39.55%
2015-12-316.18171.33%
2014-12-312.28-16.16%
2013-12-312.72-24.72%
2012-12-313.6155.46%
2011-12-312.327.73%
2010-12-312.1531.8%
2009-12-311.6387.45%
2008-12-310.8717

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
AstraZeneca
AZN
6.09 726.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
6.15 734.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.40 89.65%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-154-21,036.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
2.31 214.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.25 477.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.48 507.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
4.60 525.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
4.81 553.12%๐Ÿ‡บ๐Ÿ‡ธ USA